Approved for the Drug, Denied for Where You Get It
Approved for the Drug, Denied for Where You Get It
This is a kind of denial that doesn't show up in the usual statistics, because technically it isn't a denial of the medication at all. Your prior authorization was approved. Your insurer will cover your infusion drug. But they will not cover it at the infusion center your oncologist or rheumatologist or neurologist works with. They want you to go somewhere else.
This is called a site of care requirement, and it is becoming one of the most common coverage disputes for patients receiving specialty infusion medications.
What a Site of Care Requirement Is
When a medication needs to be infused intravenously, it can generally be administered in several settings: a hospital outpatient infusion center, a physician's office, a standalone infusion clinic, or sometimes at home with a nursing service.
Insurers know that the same infusion drug can cost significantly different amounts depending on where it is administered. Hospital outpatient departments, in particular, are authorized under Medicare and commercial insurance to charge a facility fee on top of the drug cost itself. A drug that costs $4,000 at a standalone infusion clinic might cost $7,000 at a hospital outpatient infusion center because of the facility fee component.
Site of care programs are insurer policies that redirect patients away from higher-cost settings, typically hospital outpatient infusion, and toward lower-cost settings like standalone infusion centers, physician offices, or home infusion.¹
Your insurer is not saying no to the drug. They are saying: you can have the drug, but not there.
Why This Is Increasing
The use of site of care programs has grown significantly in the last several years, for a few reinforcing reasons.
Specialty drug spending is rising, and infusion drugs for autoimmune conditions, multiple sclerosis, cancer, and rare diseases are among the most expensive in the pharmacy benefit. Insurers have identified site of care as a meaningful lever for reducing costs on drugs they cannot easily deny outright.
The growth of standalone infusion clinics and home infusion services has given insurers more alternative options to point to, making site of care requirements more plausible. When the only alternative was a lower-quality setting with real clinical drawbacks, the argument was harder to make. Now that there are accredited standalone infusion centers in most markets, insurers have more cover for these policies.
Pharmacy benefit managers have added site of care management programs as a service they offer to employer plan sponsors, framing them as cost-control measures. As these programs have become standard offerings, their use has spread.¹
When You Can Push Back
Site of care requirements are not absolute, and there are specific circumstances under which a site of care appeal is likely to succeed.
Your physician has documented clinical reasons for the specific site. This is the strongest argument. If your condition requires monitoring capabilities available only at a hospital-based setting, if you have a history of infusion reactions requiring immediate intervention, if you have complex comorbidities that make a hospital-adjacent infusion necessary for safety, or if your medication requires clinical monitoring that the alternative site cannot provide, those are medical necessity arguments that the insurer must evaluate.
The key is having your physician document these reasons explicitly and in clinical terms. A note that says "patient should continue treatment at current site" is less effective than one that says "patient experienced two prior infusion reactions requiring emergency management, and administration at a setting without immediate access to emergency medical support creates a patient safety risk."
The required alternative site does not have the clinical capabilities your treatment requires. Some infusion drugs require extended monitoring times, specific nursing protocols, or pharmacy services that not all standalone infusion centers provide. If the site your insurer is directing you to does not have the capability to administer your specific medication safely, document that.
The required alternative site does not have capacity within a clinically appropriate timeframe. Some standalone infusion centers have significant wait times. If your medication is time-sensitive and the alternative site cannot schedule you within the timeframe your condition requires, document that discrepancy.
Travel and access burdens create a medical hardship. If you are elderly, have mobility limitations, or do not have transportation to the required alternative site, and the required travel creates a genuine access barrier, that may support an exception. This argument is less commonly successful on its own but can strengthen a combined appeal.
Your treatment team is at the hospital-based site. If your oncologist, rheumatologist, or neurologist is at the hospital and the infusion center there is integrated into the coordinated care they provide, the clinical continuity argument has merit. Ask your physician to document specifically how clinical coordination between the infusion team and the treating specialist affects your care quality.
How to Appeal a Site of Care Requirement
The appeal process for site of care requirements follows the same structure as other prior authorization appeals, but the documentation strategy is specific.
Start with a peer-to-peer review. As with most prior authorization disputes, a physician-to-physician call between your doctor and the insurer's medical director is often the fastest path to reversal. Ask your treating physician's office whether they will initiate a peer-to-peer, and ask them to have the clinical safety documentation ready for that call.
Request the insurer's site of care policy in writing. Your insurer should be able to provide the criteria they use to determine which patients are eligible for exceptions to site of care requirements. Understanding their own criteria helps you build an appeal that addresses those criteria directly.
Document the clinical basis for your current site. Your appeal letter should include your physician's documentation of the clinical reasons your specific situation requires the hospital-based setting. The more specific and patient-centered, the more effective.
Obtain a letter from the alternative site about its capabilities, if applicable. If the required alternative site lacks a capability that your treatment requires, a letter from that facility confirming the limitation is useful documentation.
File an internal appeal within your plan's deadline. Most plans have 30 to 180 day windows for internal appeal of prior authorization decisions. Do not let that window pass while you are sorting out the logistics.
Request external review if your internal appeal fails. External review by an independent review organization is binding on your insurer. External reviewers evaluate medical necessity based on generally accepted clinical standards, and arguments about patient safety and clinical necessity for a specific site can be persuasive at external review.
The Balance of Interests
It is worth being clear about what is at stake here. Site of care requirements are cost-control measures, not clinical decisions. Your insurer is not saying that hospital-based infusion is clinically inferior. They are saying it costs more, and they would prefer to pay less.
That is a legitimate interest. The lower-cost alternative sites are often perfectly adequate for many patients. When the lower-cost site is clinically appropriate for you, using it may not cause you harm.
The problem arises when the lower-cost site is not clinically appropriate for your specific situation, and the insurer treats site of care as a blanket policy rather than an individual clinical determination. The appeal process exists to surface that distinction.
Your physician's documentation is the most important piece of this. Insurers are more likely to grant exceptions when a treating physician provides specific, individualized clinical reasoning, not a form letter.
What This Means for You
If you received a site of care requirement, the first question to ask your physician is: is there a clinical reason I specifically need to receive this infusion at this facility? If the answer is yes, work with your physician to document those reasons clearly and appeal.
If the answer is no, it is worth understanding what the alternative site looks like before deciding whether to push back. Some standalone infusion centers are excellent. Some have long wait times or are inconveniently located. Your experience of the alternative site matters too.
Ellen can help you decode your coverage determination, understand your insurer's site of care criteria, and prepare an appeal framework to bring to your physician.
Frequently Asked Questions
Is a site of care requirement the same as a denial?
Functionally, it can be. If your insurer approves your medication but conditions coverage on receiving it at a site that is inaccessible or clinically inappropriate for you, the access barrier is real even if the approval itself was granted.
Does my insurer have to cover home infusion if I request it?
Not automatically. Whether home infusion is covered depends on your specific plan and the specific medication. Some drugs can be administered at home; others require clinical oversight that home infusion cannot provide. Your plan documents will specify what is covered.
What if I already received an infusion at the hospital site and am being redirected going forward?
Your insurer can generally change site of care requirements at renewal or upon new prior authorization. Continuity of care arguments are worth making if you have an established, stable treatment relationship at your current site, but they are not automatically controlling.
What clinical reasons are most likely to support a site of care exception?
History of infusion reactions, complex comorbidities requiring emergency-adjacent monitoring, specific drug preparation or monitoring requirements that the alternative site cannot meet, and clinical integration between the infusion site and your treating specialist.
Sources
Ellen can help you understand your coverage determination and build an appeal grounded in your physician's clinical assessment. Start at EllenRx.com.